Charles Sande
5 results
Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape.Mazur NI, Terstappen J, Baral R, Bardaji A, Beutels P, Buchholz UJ, Cohen C, Crowe JE, Cutland CL, Eckert L, Feikin D, Fitzpatrick T, Fong Y, Graham BS, Heikkinen T, Higgins D, Hirve S, Klugman KP, Kragten-Tabatabaie L, Lemey P, Libster R, Lowensteyn Y, Mejias A, Munoz FM, Munywoki PK, Mwananyanda L, Nair H, Nunes MC, Ramilo O, Richmond P, Ruckwardt TJ, Srikantiah P, Thacker N, Waldstein KA, Weinberger D, Wildenbeest J, Wiseman D, Zar HJ, Zambon M, Bont L
Lancet Infect Dis, (2022). 23:e2-e21
Respiratory syncytial virus in young children: community cohort study integrating serological surveys, questionnaire and electronic health records, Born in Bradford cohort, England, 2008 to 2013.Zylbersztejn A, Pembrey L, Goldstein H, Berbers G, Schepp R, van der Klis F, Mason D, Wright J, Smyth R, Hardelid P
Euro Surveill, (2021). 26:2000023
Quantifying maternally derived respiratory syncytial virus specific neutralising antibodies in a birth cohort from coastal Kenya.Nyiro JU, Mutunga M, Kiyuka PK, Munywoki PK
Vaccine, (2015). 33:1797-801
Identifying infections with respiratory syncytial virus by using specific immunoglobulin G (IgG) and IgA enzyme-linked immunosorbent assays with oral-fluid samples.Okiro EA, Mutunga M, Medley GF, Cane PA
J Clin Microbiol, (2008). 46:1659-62
Comparison of strain-specific antibody responses during primary and secondary infections with respiratory syncytial virus.Scott PD, Ochola R, Ngama M, Okiro EA, Medley GF, Cane PA
J Med Virol, (2007). 79:1943-50